← Browse by Condition
Medical Condition

prehabilitation

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for prehabilitation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — prehabilitation Clinical Trials

How many clinical trials are currently recruiting for prehabilitation?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for prehabilitation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for prehabilitation?
prehabilitation research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a prehabilitation clinical trial?
Eligibility criteria for prehabilitation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Hospital Clinic of Barcelona 1 trial
Taipei Veterans General Hospital, Taiwan 1 trial
Universidad de La Frontera 1 trial
Pontificia Universidad Catolica de Chile 1 trial

Recruiting Clinical Trials

NCT07107594
Recruiting
Multimodal Prehabilitation Program That Combines Physical Exercise, Psychological Intervention and Nutritional Support to Improve the Response to Neoadjuvant Chemoterhapy in Early Breast Cancer Patients
Enrollment
214 pts
Location
Spain
Sponsor
Hospital Clinic of Barcelona
View Trial →
NCT07562100
Recruiting
Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer
Enrollment
650 pts
Location
Taiwan
Sponsor
Taipei Veterans General Hospit...
View Trial →
NCT06309290
Recruiting
Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy
Enrollment
68 pts
Location
Chile
Sponsor
Universidad de La Frontera
View Trial →
NCT06857981
Recruiting
Patient's Database: Prepare for Your Surgery Program
Enrollment
120 pts
Location
Chile
Sponsor
Pontificia Universidad Catolic...
View Trial →

Related Conditions

breast cancer early stage breast cancer stage 1 3 (1) oral cancer (1) psychological distress (1) communication aids for disabled (1) physiotherapy (1) return to work (1) physical symptom distress (1) motor function (1) rehabilitation (1) quality of life (1) cost effectiveness (1) artifical intelligence (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology